Biologics in eosinophilic esophagitis.

Area of Science:

• Gastroenterology
• Immunology
• Pharmacology

Background:

• Eosinophilic esophagitis (EoE) is a growing chronic inflammatory esophageal condition.
• Many patients remain symptomatic despite standard treatments like diet and steroids.

Purpose of the Study:

• To review the safety and efficacy of monoclonal antibodies (mAbs) for EoE treatment.
• To explore emerging biologic therapies for EoE.

Main Methods:

• Literature review of clinical trials and studies on biologics for EoE.
• Analysis of safety and efficacy data for monoclonal antibodies targeting EoE pathways.

Main Results:

• Monoclonal antibodies targeting specific EoE effectors show potential for clinical and histologic benefit.
• Biologics may offer improved symptom control and histological outcomes in EoE patients.

Conclusions:

• Monoclonal antibodies represent a promising therapeutic option for eosinophilic esophagitis.
• These biologics may provide a safer alternative with fewer adverse effects compared to conventional treatments.